Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 4, No 2 (2012) Clinical characteristics of multiple sclerosis in the Tomsk region Abstract  similar documents
V M Alifirova, M A Titova
"... Two hundred and eighty patients (102 men and 178 women; mean age 38.8ё0.7 years) with multiple ..."
 
Vol 6, No 3 (2014) Visual evoked potentials in examining the visual analyzer in patients with multiple sclerosis Abstract  similar documents
S. M. Karpov, Z. B. Pazhigova, E. N. Karpova
"... with multiple sclerosis (MS) to optimize the early diagnosis of the disease. Patients and methods. Seventy-nine ..."
 
Vol 7, No 1 (2015) Time course of changes in the development of gait disorders in multiple sclerosis Abstract  similar documents
A. M. Petrov, I. D. Stolyarov, G. G. Shkilnyuk, A. G. Ilves, K. K. Mineev, V. V. Lebedev, T. L. Tsvetkova
"... Objective: to estimate the time course of changes in foot biomechanical function as multiple ..."
 
Vol 7, No 1 (2015) Non-biological complex drugs and their analogues in the pathogenetic therapy of multiple sclerosis: Issues of efficacy and safety in clinical use Abstract  similar documents
I. D. Stolyarov, A. M. Petrov, M. V. Votintseva, I. G. Nikiforova
"... of multiple sclerosis (MS) – glatiramer acetate (GA, Copaxone®, Teva) in large Russian MS centers ..."
 
Vol 3, No 2 (2011) Psychological features of patients with central pain syndrome in multiple sclerosis Abstract  similar documents
M. V. Churyukanov, V. V. Alekseev, M. L. Kukushkin, N. N. Yakhno
"... ) in multiple sclerosis (MS). There was a variety of the clinical manifestations of CPS. An association of pain ..."
 
Vol 8, No 4 (2016) USE OF DIMETHYL FUMARATE IN THE TREATMENT OF MULTIPLE SCLEROSIS: CLINICAL AND ECONOMIC ANALYSIS Abstract  similar documents
V. R. Mkrtchyan, L. V. Brylev, I. A. Shpak, A. M. Sergeev
"... dimethyl fumarate in the treatment of multiple sclerosis (MS) in European countries. A pharmacoeconomic ..."
 
Vol 8, No 4 (2016) GLATIRAMER ACETATE IS A FIRST-LINE DUAL-ACTION DRUG FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS Abstract  similar documents
T. E. Shmidt
"... Multiple sclerosis (MS) is the most common and potentially disabling disease of the central ..."
 
Vol 7, No 3 (2015) Pharmacoeconomic analysis of the use of first- and second-line drugs in the treatment of multiple sclerosis Abstract  similar documents
V. R. Mkrtchyan, L. V. Brylev, O. V. Davydova, A. V. Belyanin, I. A. Shpak, A. M. Sergeev
"... drugs in the treatment of multiple sclerosis through cost, cost-effectiveness, and budget impact ..."
 
1 - 8 of 8 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)